ACAD - ACADIA PHARMACEUTICALS INC
23.39
0.890 3.805%
Share volume: 1,919,276
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$22.50
0.89
0.04%
Summary score
46%
Profitability
45%
Dept financing
25%
Liquidity
75%
Performance
44%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-1.1%
Return on sales
-6.56%
Return on invested capital
0%
Total debt ratio
35.74%
Debt ratio change over timeo
-0.91%
Current Ratio
3.05%
Quick Ratio
2.95%
Cash Position Ratio
0.84%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
2.08%
Return on sales
9.77%
Return on invested capital
0%
Total debt ratio
29.48%
Debt ratio change over timeo
0%
Current Ratio
3.16%
Quick Ratio
3.07%
Cash Position Ratio
0.71%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
1.15%
Return on sales
6.12%
Return on invested capital
0%
Total debt ratio
21.53%
Debt ratio change over time
0%
Current Ratio
3.83%
Quick Ratio
3.71%
Cash Position Ratio
0.64%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-105.77%
Return on sales
-131.27%
Return on invested capital
0%
Total debt ratio
-90.81%
Debt ratio change over time
-0.91%
Current Ratio
0.45%
Quick Ratio
0.43%
Cash Position Ratio
-0.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACAD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -1.1% | 4.74% | 3.19% | 1.73% |
| Return on sales | -6.56% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 35.74% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -0.91% | -20.57% | -85.61% | 17.33% |
| Dept financing | 9% | 21% | 16% | 50% |
| Current Ratio | 3.16% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.07% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.71% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 23% | 32% | 20% |
| Short-term ratios | ACAD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 2.08% | 6.06% | 4.18% | 1.7% |
| Return on sales | 9.77% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 65% | 50% | 34% | 23% |
| Total debt ratio | 29.48% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 20% | 15% | 25% |
| Current Ratio | 3.16% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.07% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.71% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 26% | 31% | 16% |